| Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ... The lancet 387 (10027), 1540-1550, 2016 | 7069 | 2016 |
| Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study EEW Cohen, D Soulières, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ... The Lancet 393 (10167), 156-167, 2019 | 1558 | 2019 |
| Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC) SM Gadgeel, NA Pennell, MJ Fidler, B Halmos, P Bonomi, J Stevenson, ... Journal of Thoracic Oncology 13 (9), 1393-1399, 2018 | 203 | 2018 |
| Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer JH Newman, CB Chesson, NL Herzog, PK Bommareddy, SM Aspromonte, ... Proceedings of the National Academy of Sciences 117 (2), 1119-1128, 2020 | 175 | 2020 |
| Esophageal carcinoma advances in treatment results for locally advanced disease A Herskovic, W Russell, M Liptay, MJ Fidler, M Al-Sarraf Annals of oncology 23 (5), 1095-1103, 2012 | 137 | 2012 |
| PTEN, RASSF1 and DAPK site‐specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients L Buckingham, L Penfield Faber, A Kim, M Liptay, C Barger, S Basu, ... International journal of cancer 126 (7), 1630-1639, 2010 | 118 | 2010 |
| Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma DM Cognetti, JM Johnson, JM Curry, ST Kochuparambil, D McDonald, ... Head & neck 43 (12), 3875-3887, 2021 | 115 | 2021 |
| Treatment of advanced squamous cell carcinoma of the lung: a review BA Derman, KF Mileham, PD Bonomi, M Batus, MJ Fidler Translational lung cancer research 4 (5), 524, 2015 | 111 | 2015 |
| Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial RS Herbst, P Baas, JL Perez-Gracia, E Felip, DW Kim, JY Han, JR Molina, ... Annals of Oncology 30 (2), 281-289, 2019 | 110 | 2019 |
| Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls MJ Fidler, DD Shersher, JA Borgia, P Bonomi Therapeutic advances in medical oncology 4 (2), 51-60, 2012 | 80 | 2012 |
| Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer BA Derman, JN Macklis, MS Azeem, S Sayidine, S Basu, M Batus, ... BMC cancer 17, 1-6, 2017 | 74 | 2017 |
| Health-related quality of life in KEYNOTE-010: a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1 … F Barlesi, EB Garon, DW Kim, E Felip, JY Han, JH Kim, MJ Ahn, MJ Fidler, ... Journal of Thoracic Oncology 14 (5), 793-801, 2019 | 69 | 2019 |
| The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non–small cell lung cancer patients treated with … MJ Fidler, A Argiris, JD Patel, DH Johnson, A Sandler, VM Villaflor, ... Clinical cancer research 14 (7), 2088-2094, 2008 | 62 | 2008 |
| Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non‐small cell lung cancer in the National Cancer Data Base DJ Sher, M Koshy, MJ Liptay, MJ Fidler Cancer 120 (13), 2060-2068, 2014 | 56 | 2014 |
| Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck … JP Machiels, Y Tao, L Licitra, B Burtness, M Tahara, D Rischin, G Alves, ... The Lancet Oncology 25 (5), 572-587, 2024 | 48 | 2024 |
| Cost-effectiveness analysis of chemoradiation therapy versus transoral robotic surgery for human papillomavirus–associated, clinical N2 oropharyngeal cancer DJ Sher, MJ Fidler, RB Tishler, K Stenson, S Al-Khudari International Journal of Radiation Oncology* Biology* Physics 94 (3), 512-522, 2016 | 46 | 2016 |
| The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients MJ Fidler, CL Fhied, J Roder, S Basu, S Sayidine, I Fughhi, M Pool, ... Bmc Cancer 18, 1-9, 2018 | 44 | 2018 |
| Praluzatamab ravtansine, a CD166-targeting antibody–drug conjugate, in patients with advanced solid tumors: an open-label phase I/II trial V Boni, MJ Fidler, HT Arkenau, A Spira, F Meric-Bernstam, N Uboha, ... Clinical Cancer Research 28 (10), 2020-2029, 2022 | 43 | 2022 |
| Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer DJ Sher, MJ Fidler, MJ Liptay, M Koshy Lung cancer 88 (3), 267-274, 2015 | 38 | 2015 |
| Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients … MJ Edelman, MT Tan, MJ Fidler, RE Sanborn, G Otterson, LV Sequist, ... Journal of Clinical Oncology 33 (2), 189-194, 2015 | 38 | 2015 |
